Diabetes Mellitus and Risk of Hepatocellular Carcinoma
Joint Authors
Li, Xu
Gao, Pujun
Wang, Xiaocong
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-10, 10 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-12-12
Country of Publication
Egypt
No. of Pages
10
Main Subjects
Abstract EN
The occurrence of hepatocellular carcinoma (HCC) is two to three times higher in patients with diabetes mellitus (DM), the prevalence of which is increasing sharply worldwide.
The purpose of this review was to describe clinical links between DM and HCC and potential biological mechanisms that may account for this association.
We evaluated the role of potential pathways that could account for the development of HCC with different etiologies in the presence of DM.
In addition, we also briefly discuss the potential effect of other factors such as type and dosage of antidiabetic medicines and duration of DM on HCC risk.
American Psychological Association (APA)
Li, Xu& Wang, Xiaocong& Gao, Pujun. 2017. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. BioMed Research International،Vol. 2017, no. 2017, pp.1-10.
https://search.emarefa.net/detail/BIM-1137486
Modern Language Association (MLA)
Li, Xu…[et al.]. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. BioMed Research International No. 2017 (2017), pp.1-10.
https://search.emarefa.net/detail/BIM-1137486
American Medical Association (AMA)
Li, Xu& Wang, Xiaocong& Gao, Pujun. Diabetes Mellitus and Risk of Hepatocellular Carcinoma. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-10.
https://search.emarefa.net/detail/BIM-1137486
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1137486
